News
Watch
Journals
Conferences
Events
Resources
CE
About AJMC
Subscribe

Spotlight -

Free In-Person Regional Events Focused on Oncology and Population Health

James F. Lancaster, PhD

Articles by James F. Lancaster, PhD

Safety and Clinical Efficacy of Zileuton in Patients with Chronic Asthma

ByStephen C. Lazarus, MD,Theodore Lee, MD,James P. Kemp, MD,Sally Wenzel, MD,Louise M. Dube, PhD,Rachel F. Ochs, MD, JD,Pierre J. Carpentier, MD,James F. Lancaster, PhD,the Zileuton Study Group

June 1st 1998

Randomized Trial of Zileuton in Patients with Moderate Asthma: Effect of Reduced Dosing Frequency and Amounts on Pulmonary Function and Asthma Symptoms

ByLawrence M. DuBuske, MD,Jay Grossman, MD,Louise M. Dube, PhD,Linda J. Swanson, PhD,James F. Lancaster, PhD,the Zileuton Study Group

April 1st 1997

Latest Updated Articles

Trending on AJMC

FDA Approves Imlunestrant Plus Abemaciclib for Breast Cancer

All 50 States Apply for CMS's GENEROUS Model, With $64.3B in Savings Projected

Lung Cancer Progress Drives Down US Cancer Death Rates

Higher CPAP Adherence Linked With Lower Mortality Risk in OSA

World Alzheimer Day: Young-Onset Alzheimer Disease Often Misdiagnosed